CDKN2B and central nervous system cancer: Early cytogenetic studies identified recurrent loss of the short arm of chromosome 9 in glioma cell lines [21,22,23,36], many involving the 9p21 locus [22,37], which includes CDKN2A and CDKN2B [23,36].